Thursday, November 21, 2024
Home 2024

Yearly Archives: 2024

2024 Watch List

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

Editor / Curator -
All News

Adial Pharma (ADIL). Why Quit Drinking When You Can Just Cut...

Editor / Curator -
2024 Watch List

Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX)...

Editor / Curator -
2024 Watch List

Geovax (GOVX) – City of Hope Covid Vaccine for Chronic Lymphocytic...

Editor / Curator -
2024 Watch List

The Extraordinary Dr. Koffman, Who Beat Leukemia.

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Conference Call at 4:30 ET, the 29th.

Editor / Curator -
All News

Vaxart (VXRT) Gains $171 Million in Market Value After $9.2 Million...

Editor / Curator -
All News

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Editor / Curator -
2024 Watch List

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

Editor / Curator -
2024 Watch List

GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.

Editor / Curator -
1...3456Page 4 of 6

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.